Devie Medical
Deviemedical is transforming the treatment of bacterial endocarditis with an innovative transcatheter platform for drug delivery. Their mission is to address a significant unmet medical need in cardiology by merging advanced medical technology with proprietary pharmacological concepts, pushing the boundaries of cardiovascular interventions.
Industries
pharmaceutical
Nr. of Employees
small (1-50)
Devie Medical
Bachstraße 18, 07743 Jena, Germany
Patents
System for treating, preventing and/or replacing a heart valve, in particular an inflamed, infected, thrombosed or degenerated heart valve
US-12257147-B2
View Details
System for treating, preventing and/or replacing a heart valve, in particular an inflamed, infected, thrombosed or degenerated heart valve
US-12257147-B2
View DetailsProducts
Transcatheter drug delivery platform (in development)
A catheter-delivered platform currently under development to enable localized delivery of therapeutic agents to cardiac structures for the treatment of bacterial endocarditis.
Transcatheter drug delivery platform (in development)
A catheter-delivered platform currently under development to enable localized delivery of therapeutic agents to cardiac structures for the treatment of bacterial endocarditis.
Services
R&D services to develop catheter-delivered therapeutic platforms combining device engineering and pharmacological design for treatment of cardiac infections.
R&D services to develop catheter-delivered therapeutic platforms combining device engineering and pharmacological design for treatment of cardiac infections.
Expertise Areas
- Transcatheter therapeutic development
- Drug-device combination development
- Interventional cardiology therapies
- Targeted antimicrobial therapy for endocarditis
Key Technologies
- Catheter-based drug delivery systems
- Drug-device combination technologies
- Localized antimicrobial delivery
- Interventional cardiology device engineering